Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

$ATTOPress releaseAug 6, 2026, 4:05 PM ETRead the release

Attovia Therapeutics closed its upsized initial public offering of 19,550,000 shares at a price of $17.00 per share, generating aggregate gross proceeds of approximately $332.4 million. The underwriters exercised their option in full to purchase an additional 2,550,000 shares, indicating strong investor demand.

Key figures

Offering Price
17
Shares Offered
19550000
Greenshoe shares
2550000
Gross proceeds usd
332400000

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    ATTO: Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares — AI Analysis | Signal8